Last updated on January 2020

A First-in-human Study of the Safety Pharmacokinetics Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors

Find a site near you

Start Over

Investigational Site Number 2500004

Paris Cedex 10, France
  Connect »

Investigational Site Number 2500001

Villejuif Cedex, France
  Connect »